Anne Rigg

3.0k total citations
37 papers, 971 citations indexed

About

Anne Rigg is a scholar working on Oncology, General Health Professions and Cancer Research. According to data from OpenAlex, Anne Rigg has authored 37 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 7 papers in General Health Professions and 7 papers in Cancer Research. Recurrent topics in Anne Rigg's work include COVID-19 and healthcare impacts (8 papers), Breast Cancer Treatment Studies (6 papers) and Economic and Financial Impacts of Cancer (5 papers). Anne Rigg is often cited by papers focused on COVID-19 and healthcare impacts (8 papers), Breast Cancer Treatment Studies (6 papers) and Economic and Financial Impacts of Cancer (5 papers). Anne Rigg collaborates with scholars based in United Kingdom, Australia and United States. Anne Rigg's co-authors include Nicholas R. Lemoine, Mieke Van Hemelrijck, Beth Russell, Charlotte Moss, Karol Sikora, Justin C. St. John, Hardev Pandha, Heidi Lempp, Graham Thornicroft and Elizabeth Barley and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Anne Rigg

34 papers receiving 938 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Rigg United Kingdom 13 379 209 159 150 141 37 971
Hongbo Yang United States 24 443 1.2× 326 1.6× 256 1.6× 175 1.2× 110 0.8× 136 1.9k
Luís Madero Spain 24 562 1.5× 303 1.4× 153 1.0× 175 1.2× 249 1.8× 76 1.6k
Jun She China 15 186 0.5× 315 1.5× 287 1.8× 154 1.0× 58 0.4× 26 989
Antonis Kattamis Greece 29 141 0.4× 339 1.6× 190 1.2× 73 0.5× 146 1.0× 183 3.5k
Qiwen Fang China 11 385 1.0× 117 0.6× 126 0.8× 187 1.2× 47 0.3× 34 1.2k
Kurt Leibundgut Switzerland 21 469 1.2× 213 1.0× 139 0.9× 103 0.7× 187 1.3× 92 1.4k
Hana Fakhoury Saudi Arabia 16 230 0.6× 299 1.4× 147 0.9× 73 0.5× 129 0.9× 71 1.2k
Samuel Ariad Israel 21 781 2.1× 256 1.2× 181 1.1× 129 0.9× 50 0.4× 109 1.5k
Samart Pakakasama Thailand 25 334 0.9× 434 2.1× 136 0.9× 119 0.8× 79 0.6× 130 1.6k
Tim Harris United Kingdom 15 308 0.8× 290 1.4× 88 0.6× 49 0.3× 92 0.7× 30 1.2k

Countries citing papers authored by Anne Rigg

Since Specialization
Citations

This map shows the geographic impact of Anne Rigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Rigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Rigg more than expected).

Fields of papers citing papers by Anne Rigg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Rigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Rigg. The network helps show where Anne Rigg may publish in the future.

Co-authorship network of co-authors of Anne Rigg

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Rigg. A scholar is included among the top collaborators of Anne Rigg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Rigg. Anne Rigg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Rigg, Anne, Emma Kemp, Bogda Koczwara, et al.. (2024). Feasibility, acceptability, and preliminary efficacy of a self-directed online psychosocial intervention for women with metastatic breast cancer: Finding My Way-Advanced. Supportive Care in Cancer. 32(11). 744–744. 1 indexed citations
4.
George, Gincy, Beth Russell, Anne Rigg, A C C Coolen, & Mieke Van Hemelrijck. (2023). Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic?. PubMed. Volume 14. 95–100.
5.
Lumlertgul, Nuttha, Pietro Vassallo, Nina Seylanova, et al.. (2023). Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study. European Journal of Cancer. 191. 112967–112967. 6 indexed citations
6.
Russell, Beth, Charlotte Moss, Elke Rammant, et al.. (2022). Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic. Future Oncology. 18(18). 2201–2216. 1 indexed citations
7.
Turnbull, Arran, Samir Patel, Carlos Martínez-Pérez, Anne Rigg, & Olga Oikonomidou. (2020). Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer. Breast Cancer Research and Treatment. 186(1). 237–245. 8 indexed citations
8.
Russell, Beth, Charlotte Moss, Anne Rigg, & Mieke Van Hemelrijck. (2020). COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?. ecancermedicalscience. 14. 1023–1023. 212 indexed citations
9.
Sirohi, Bhawna, Marina Parton, Anup Vinayan, et al.. (2020). The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience. Breast Cancer Research and Treatment. 180(3). 809–817. 26 indexed citations
10.
Moss, Charlotte, Fidelma Cahill, Deborah Enting, et al.. (2020). Guy’s cancer cohort – real world evidence for cancer pathways. BMC Cancer. 20(1). 187–187. 5 indexed citations
11.
12.
Parton, Marina, Anup Vinayan, Stephanie Sutherland, et al.. (2017). The impact of Oncotype DX breast cancer assay results on clinical practice: A UK experience. Annals of Oncology. 28. v57–v58. 1 indexed citations
13.
Howard, Louise M., Elizabeth Barley, Elizabeth Davies, et al.. (2010). Cancer diagnosis in people with severe mental illness: practical and ethical issues. The Lancet Oncology. 11(8). 797–804. 125 indexed citations
14.
O’Brien, Mary, Anne Rigg, Alexandra Léary, et al.. (2006). Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients. British Journal of Cancer. 95(12). 1632–1636. 96 indexed citations
15.
Rigg, Anne & Nicholas R. Lemoine. (2001). Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo. Cancer Gene Therapy. 8(11). 869–878. 63 indexed citations
16.
Sirohi, Bhawna, R Powles, S Kulkarni, et al.. (2001). Glomerular filtration rate prior to high-dose melphalan 200 mg/m2as a surrogate marker of outcome in patients with myeloma. British Journal of Cancer. 85(3). 325–332. 28 indexed citations
17.
Halford, Sarah, et al.. (2000). Adjuvant mitozantrone chemotherapy in advanced prostate cancer. British Journal of Urology. 86(6). 675–680. 67 indexed citations
18.
Rigg, Anne & N R Lemoine. (1999). Genetic Prodrug Activation Therapy for Pancreatic Cancer. Annals of the New York Academy of Sciences. 880(1). 319–325. 5 indexed citations
19.
Rigg, Anne, David Cunningham, M. Gore, et al.. (1997). A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas. British Journal of Cancer. 75(1). 101–105. 12 indexed citations
20.
Rigg, Anne & Karol Sikora. (1997). Genetic prodrug activation therapy. Molecular Medicine Today. 3(8). 359–366. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongbo Yang Breakdown of academic impact, for papers by Luís Madero Breakdown of academic impact, for papers by Jun She Breakdown of academic impact, for papers by Antonis Kattamis Breakdown of academic impact, for papers by Qiwen Fang Breakdown of academic impact, for papers by Kurt Leibundgut Breakdown of academic impact, for papers by Hana Fakhoury Breakdown of academic impact, for papers by Samuel Ariad Breakdown of academic impact, for papers by Samart Pakakasama Breakdown of academic impact, for papers by Tim Harris
Rankless by CCL
2026